Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: Termination of CNS autoimmune inflammation and modulation by interferon-beta

GLIA

Volumn 43, Issue 3, 2003, Pages 231-242

  Chan, Andrew ^a,e   Seguin, Rosanne ^b   Magnus, Tim ^a,c   Papadimitriou, Christina ^a,d   Toyka, Klaus V ^a   Antel, Jack P ^b   Gold, Ralf ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MCGILL UNIVERSITY   (Canada)

^c SAARLAND UNIVERSITY   (Germany)

^d AHEPA UNIVERSITY HOSPITAL   (Greece)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Experimental autoimmune encephalomyelitis; Multiple sclerosis; T cell apoptosis

Indexed keywords

BETA INTERFERON; CYTOKINE; IMMUNOMODULATING AGENT; INTERLEUKIN 10; MYELIN BASIC PROTEIN; PHOSPHATIDYLSERINE; PHOSPHATIDYLSERINE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MICROGLIA; MONONUCLEAR CELL; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; ENCEPHALITIS; HUMANS; INTERFERON-BETA; INTERLEUKIN-10; MICROGLIA; MYELIN BASIC PROTEINS; OLIGOPEPTIDES; PHAGOCYTOSIS; PHOSPHOSERINE; RATS; RATS, INBRED LEW; T-LYMPHOCYTES; UP-REGULATION;

EID: 0041864080     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10258     Document Type: Article

References (47)

1. Aloisi F. 2001. Immune function of microglia. Glia 36:165-179.
2. Bauer J, Stadelmann C, Bancher C, Jellinger K, Lassmann H. 1999. Apoptosis of T lymphocytes in acute disseminated encephalomyelitis. Acta Neuropathol 97:543-546.
3. Bauer J, Rauschka H, Lassmann H. 2001. Inflammation in the nervous system: the human perspective. Glia 36:235-243.
4. Becher B, Antel JP. 1996. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18:1-10.
5. Becher B, Prat A, Antel JP. 2000. Brain-immune connection: immunoregulatory properties of CNS-resident cells. Glia 29:293-304.
6. Chabot S, Yong VW. 2000. Interferon beta-1b increases interleukin-10 in a model of T cell-microglia interaction: relevance to MS. Neurology 55:1497-1505.
7. Chan A, Gold R, Giegerich G, Herrmann T, Jung S, Toyka KV, Hartung H-P. 1999. Usage of Vβ3.3 T-cell receptor by myelin basic protein-specific encephalitogenic T-cell lines in the Lewis rat. J Neurosci Res 58:214-225.
8. Chan A, Magnus T, Gold R. 2001. Phagocytosis of apoptotic inflammatory cells by microglia and modulation by different cytokines: mechanism for removal of apoptotic cells in the inflamed nervous system. Glia 33:87-95.
9. Chan A, Papadimitriou C, Graf W, Toyka KV, Gold R. 2003. Effects of polyclonal immunoglobulins (IVIg) and other immunomodulatory agents on microglial phagocytosis of apoptotic inflammatory T-cells. J Neuroimmunol 135:161-165.
10. De Simone R, Ajmone-Cat MA, Nicolini A, Minghetti L. 2002. Expression of Phosphatidylserine Receptor and down-regulation of proinflammatory molecule production by its natural ligand in rat microglial cultures. J Neuropathol Exp Neurol 61:237-244.
11. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207-2216.
12. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. 2000. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405:85-90.
13. Fadok VA, Bratton DL, Henson PM. 2001a. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest 108:957-962.
14. Fadok VA, Xue D, Henson P. 2001b. If phosphatidylserine is the death knell, a new phosphatidylserine-specific receptor is the bellringer. Cell Death Differ 8:582-587.
15. Galati G, Rovere P, Citterio G, Bondanza A, Scagliette U, Bucci E, Heltai S, Fascio U, Rugarli C, Manfredi AA. 2000. In vivo administration of GM-CSF promotes the clearance of apoptotic cells: effects on monocytes and polymorphonuclear leukocytes. J Leukoc Biol 67:174-182.
16. Giles KM, Hart SP, Haslett C, Rossi AG, Dransfield I. 2000. An appetite for apoptotic cells? Controversies and challenges. Br J Haematol 109:1-12.
17. Gold R, Hartung HP, Lassmann H. 1997. T cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. TINS 20:399-404.
18. Hart SP, Dougherty GJ, Haslett C, Dransfield I. 1997. CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages. J Immunol 159:919-925.
19. Henson PM, Bratton DL, Fadok VA. 2001. The phosphatidylserine receptor: a crucial molecular switch? Nat Rev Mol Cell Biol 2:627-633.
20. Hirt UA, Gantner F, Leist M. 2000. Phagoeytosis of nonapoptotic cells dying by caspase-independent mechanisms. J Immunol 164:6520-6529.
21. Hoffmann PR, deCathelineau AM, Ogden CA, Leverrier Y, Bratton DL, Daleke DL, Ridley AJ, Fadok VA, Henson PM. 2001. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol 155:649-659.
22. Hohlfeld R. 1997. Biotechnological agents for the immunotherapy of multiple sclerosis. Brain 120:865-916.
23. Hughes J, Liu YQ, van Damme J, Savill J. 1997. Human glomerular mesangial cell phagocytosis of apoptotic neutrophils: mediation by a novel CD36-independent vitronectin receptor thrombospondin recognition mechanism that is uncoupled from chemokine secretion. J Immunol 158:4389-4397.
24. Kaser A, Deisenhammer F, Berger T, Tilg H. 1999. Interferon-β1b augments activation-induced T-cell death in multiple sclerosis patients. Lancet 353:1413-1414.
25. Kiefer R, Kieseier BC, Stoll G, Hartung HP. 2001. The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol 64:109-127.
26. Leussink VI, Jung S, Merschdorf U, Toyka KV, Gold R. 2001. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes. Arch Neurol 58:91-97.
27. Magnus T, Chan A, Grauer O, Toyka KV, Gold R. 2001. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J Immunol 167:5004-5010.
28. Magnus T, Chan A, Savill J, Toyka KV, Gold R. 2002. Phagocytic removal of apoptotic, inflammatory lymphocytes in the central nervous system by microglia and its functional implications. J Neuroimmunol 130:1-9.
29. Morse RH, Seguin R, McCrea EL, Antel JP. 2001. NK cell-mediated lysis of autologous human oligodendrocytes. J Neuroimmunol 116:107-115.
30. Nguyen KB, Pender MP. 1998. Phagocytosis of apoptotic lymphocytes by oligodendrocytes in experimental autoimmune encephalomyelitis. Acta Neuropathol 95:40-46.
31. Ozawa K, Suchanek G, Breitschopf H, Brück W, Budka H, Jellinger K, Lassmann H. 1994. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117:1311-1322.
32. Pender MP, Rist MJ. 2001. Apoptosis of inflammatory cells in immune control of the nervous system: role of glia. Glia 36:137-144.
33. Perry VH. 1998. A revised view of the central nervous system micro-environment and major histocompatibility complex class II antigen presentation. J Neuroimmunol 90:113-121.
34. Pette M, Gold R, Pette DF, Hartung H-P, Toyka KV. 1995. Mafosfamide induces DNA fragmentation and apoptosis in human T-lymphocytes: a possible mechanism of its immunosuppressive action. Immunopharmacology 30:59-69.
35. Ren Y, Savill J. 1998. Apoptosis: the importance of being eaten. Cell Death Differ 5:563-568.
36. Rolak LA. 2001. Multiple sclerosis treatment 2001. Neurol Clin 19:107-118.
37. Rudick RA, Ransohoff RM, Lee JC, Peppler R, Yu M, Mathisen PM, Tuohy VK. 1998. In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis. Neurology 50:1294-1300.
38. Ruuls SR, De Labie MCDC, Weber KS, Botman CAD, Groenestein RJ, Dijkstra CD, Olsson T, van der Meide PH. 1996. The length of treatment determines whether IFN-β prevents or aggravates experimental autoimmune encephalomyelitis in Lewis rats. J Immunol 157:5721-5731.
39. Savill J, Dransfield I, Hogg N, Haslett C. 1990. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343:170-173.
40. Savill J, Dransfield I, Gregory C, Haslett C. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2:965-975.
41. Schmidt J, Gold R, Zettl UK, Hartung HP, Toyka KV. 2000. T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy. Brain 123:1431-1441.
42. Schmidt J, Sturzebecher S, Toyka KV, Gold R. 2001. Interferon-beta treatment of experimental autoimmune encephalomyelitis leads to rapid nonapoptotic termination of T cell infiltration. J Neurosci Res 65:59-67.
43. Streit WJ. 2002. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133-139.
44. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. 1995. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 184:39-51.
45. Yong VW, Antel JP. Culture of glial cells from human brain biopsies. In: Fedoroff S, Richardson A, editors. Protocols for neural cell culture. New York: Plenum; 1992. p 81-96.
46. Yong VW, Chabot S, Stüve O, Williams G. 1998. Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology 51:682-689.
47. Zipp F, Beyer M, Gelderblom H, Wernet D, Zschenderlein R, Weller M. 2000. No induction of apoptosis by IFN-beta in human antigen-specific T cells. Neurology 54:485-487.